PT3150201T - Preparação compósita que compreende uma camada de revestimento de película que contém inibidor de 5-α-redutase e método para produzir a preparação compósita - Google Patents
Preparação compósita que compreende uma camada de revestimento de película que contém inibidor de 5-α-redutase e método para produzir a preparação compósitaInfo
- Publication number
- PT3150201T PT3150201T PT158154591T PT15815459T PT3150201T PT 3150201 T PT3150201 T PT 3150201T PT 158154591 T PT158154591 T PT 158154591T PT 15815459 T PT15815459 T PT 15815459T PT 3150201 T PT3150201 T PT 3150201T
- Authority
- PT
- Portugal
- Prior art keywords
- composite preparation
- producing
- coating layer
- film coating
- containing film
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20140081223 | 2014-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3150201T true PT3150201T (pt) | 2020-03-31 |
Family
ID=55169028
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT158154591T PT3150201T (pt) | 2014-06-30 | 2015-06-30 | Preparação compósita que compreende uma camada de revestimento de película que contém inibidor de 5-α-redutase e método para produzir a preparação compósita |
PT158160549T PT3162363T (pt) | 2014-06-30 | 2015-06-30 | Preparação compósita que compreende uma camada de revestimento de película contendo um ingrediente ativo |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT158160549T PT3162363T (pt) | 2014-06-30 | 2015-06-30 | Preparação compósita que compreende uma camada de revestimento de película contendo um ingrediente ativo |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP3150201B1 (pt) |
KR (3) | KR101780739B1 (pt) |
CN (2) | CN106659690B (pt) |
ES (2) | ES2772137T3 (pt) |
PH (2) | PH12016502537A1 (pt) |
PL (2) | PL3162363T3 (pt) |
PT (2) | PT3150201T (pt) |
RU (1) | RU2696563C9 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170113459A (ko) * | 2016-03-31 | 2017-10-12 | 한미약품 주식회사 | 타다라필 및 암로디핀 함유 고형 복합제제 |
US20190125685A1 (en) * | 2016-03-31 | 2019-05-02 | Hanmi Pharm. Co., Ltd. | Composite capsule preparation containing tadalafil and tamsulosin and having improved stability and elution rate |
WO2019035679A2 (ko) | 2017-08-18 | 2019-02-21 | (주)인벤티지랩 | 피나스테라이드를 포함하는 마이크로 입자 및 이의 제조 방법 |
KR20200099901A (ko) | 2019-02-15 | 2020-08-25 | (주)인벤티지랩 | 피나스테라이드를 포함하는 마이크로 입자를 함유한 피하 주사용 조성물 |
KR102157124B1 (ko) | 2019-12-23 | 2020-09-18 | (주)인벤티지랩 | 피나스테라이드를 포함하는 서방성 주사용 조성물 |
CN117042757A (zh) | 2020-12-31 | 2023-11-10 | 东国制药株式会社 | 表现出新溶出速率的包含他达拉非或其药学上可接受的盐和度他雄胺或其药学上可接受的盐的药物组合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005016981A1 (de) * | 2005-04-13 | 2006-10-19 | Bayer Healthcare Ag | Kombination zur Therapie bei benigner Prostatahyperplasie |
EP2210595A1 (en) * | 2009-01-14 | 2010-07-28 | LEK Pharmaceuticals d.d. | Active coating of pharmaceutical dosage forms |
BR112012015282A2 (pt) * | 2009-12-22 | 2016-03-15 | Abbott Healthcare Private Ltd | composição farmacêutica de liberação controlada |
KR101193495B1 (ko) * | 2010-02-01 | 2012-10-23 | 한미사이언스 주식회사 | 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물 |
WO2012127495A2 (en) * | 2011-02-28 | 2012-09-27 | Titan Laboratories Pvt. Ltd. | A pharmaceutical composition and process for preparation thereof |
KR101310710B1 (ko) * | 2011-03-23 | 2013-09-27 | 한미약품 주식회사 | 오메가-3 지방산 에스테르 및 HMG-CoA 환원효소 억제제를 포함하는 경구용 복합 조성물 |
KR20140013436A (ko) * | 2012-07-24 | 2014-02-05 | 한미약품 주식회사 | 메트포르민 및 로수바스타틴을 포함하는 경구용 복합 제제 |
WO2014182003A1 (en) * | 2013-05-06 | 2014-11-13 | Hanmi Pharm. Co., Ltd. | Composite formulation comprising a film coating layer containing rosuvastatin or a pharmaceutically acceptable salt thereof |
KR102240429B1 (ko) * | 2013-05-06 | 2021-04-15 | 한미약품 주식회사 | 로수바스타틴 또는 이의 약학적으로 허용되는 염이 함유된 필름 코팅층을 포함하는 복합 제형 |
-
2015
- 2015-06-30 EP EP15815459.1A patent/EP3150201B1/en active Active
- 2015-06-30 PL PL15816054T patent/PL3162363T3/pl unknown
- 2015-06-30 KR KR1020150093778A patent/KR101780739B1/ko active IP Right Grant
- 2015-06-30 PT PT158154591T patent/PT3150201T/pt unknown
- 2015-06-30 EP EP15816054.9A patent/EP3162363B1/en active Active
- 2015-06-30 RU RU2016148824A patent/RU2696563C9/ru active
- 2015-06-30 KR KR1020150093777A patent/KR20160002411A/ko active Search and Examination
- 2015-06-30 ES ES15816054T patent/ES2772137T3/es active Active
- 2015-06-30 PL PL15815459T patent/PL3150201T3/pl unknown
- 2015-06-30 CN CN201580033728.7A patent/CN106659690B/zh active Active
- 2015-06-30 CN CN201580035935.6A patent/CN106659692B/zh active Active
- 2015-06-30 PT PT158160549T patent/PT3162363T/pt unknown
- 2015-06-30 ES ES15815459T patent/ES2781110T3/es active Active
-
2016
- 2016-12-19 PH PH12016502537A patent/PH12016502537A1/en unknown
- 2016-12-19 PH PH12016502536A patent/PH12016502536A1/en unknown
-
2017
- 2017-02-24 KR KR1020170025042A patent/KR101780740B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
RU2016148824A3 (pt) | 2018-10-10 |
EP3162363A4 (en) | 2018-01-03 |
CN106659692B (zh) | 2020-08-18 |
PT3162363T (pt) | 2020-02-21 |
ES2781110T3 (es) | 2020-08-28 |
PL3162363T3 (pl) | 2020-06-15 |
PH12016502537A1 (en) | 2017-04-10 |
CN106659690A (zh) | 2017-05-10 |
KR101780740B1 (ko) | 2017-09-26 |
PH12016502536A1 (en) | 2017-04-10 |
EP3150201A1 (en) | 2017-04-05 |
RU2016148824A (ru) | 2018-07-30 |
CN106659690B (zh) | 2020-08-18 |
EP3150201A4 (en) | 2018-01-03 |
EP3162363B1 (en) | 2020-01-08 |
KR101780739B1 (ko) | 2017-09-26 |
ES2772137T3 (es) | 2020-07-07 |
EP3162363A1 (en) | 2017-05-03 |
EP3150201B1 (en) | 2020-02-19 |
KR20170026424A (ko) | 2017-03-08 |
KR20160002412A (ko) | 2016-01-07 |
KR20160002411A (ko) | 2016-01-07 |
CN106659692A (zh) | 2017-05-10 |
RU2696563C2 (ru) | 2019-08-05 |
RU2696563C9 (ru) | 2019-10-02 |
PL3150201T3 (pl) | 2020-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3413464A4 (en) | COMPOSITE SUBSTRATE AND PROCESS FOR PRODUCING COMPOSITE SUBSTRATE | |
EP3500890A4 (en) | COMPOSITE FILM, DEVICE THEREFOR AND METHOD FOR THE PRODUCTION THEREOF | |
EP3272518A4 (en) | Hard coat laminate film and method for producing same | |
EP3135488C0 (en) | COMPOSITE MATERIAL AND METHOD FOR PRODUCING THEREOF | |
EP3330009A4 (en) | METHOD FOR FORMING MULTILAYER COATING FILM | |
EP3369792A4 (en) | Antifouling film, antifouling film forming composition, antifouling film laminate, and production method for antifouling film laminate | |
EP3229260A4 (en) | Composite substrate manufacturing method and composite substrate | |
EP3397469A4 (en) | COMPOSITE LAYER TIRE | |
LT2990195T (lt) | Reljefiška ir lydant laminuota daugiasluoksnio kompozito plėvelė | |
EP3508622A4 (en) | NANO FIBER-NANO WIRE COMPOSITE AND PRODUCTION METHOD THEREFOR | |
SG11201509848PA (en) | Multilayer coating film, and method for forming multilayer coating film | |
EP3357671A4 (en) | POLYESTER FOIL, LAMINATE AND METHOD FOR THE PRODUCTION OF POLYESTER FOIL | |
PL3169638T3 (pl) | Sposób wytwarzania powlekanego substratu, płytowy substrat, obejmujący co najmniej dwie warstwy nałożone za pomocą podgrzewania i zastosowanie powlekanego substratu | |
EP3232106A4 (en) | Double-layer composite hose and manufacturing method therefor | |
PL3150201T3 (pl) | Preparat kompozytowy zawierający błonową warstwę powlekającą zawierającą inhibitor 5-reduktazy i sposób wytwarzania preparatu kompozytowego | |
EP3330403A4 (en) | SUBSTRATE / APATIT COMPOSITE OXIDE FILM COMPLEX AND METHOD FOR THE PRODUCTION THEREOF | |
EP3235869A4 (en) | Polymer-metal compound composite ink and preparation method and use thereof | |
EP3385072A4 (en) | ANTI-SLIP COMPOSITE COATING FILM, ANTI-SLIP SUBSTRATE, AND METHOD FOR MANUFACTURING ANTI-SLIP SUBSTRATE | |
EP3150305A4 (en) | Porous aluminum composite and method for manufacturing porous aluminum composite | |
EP3093141A4 (en) | Multilayer film and method for producing same | |
EP3088178A4 (en) | Laminated film, and method for manufacturing composite film | |
EP3239100A4 (en) | Composite substrate, method for forming nanocarbon film, and nanocarbon film | |
EP3130461A4 (en) | Composite film and method for manufacturing same | |
EP3118347A4 (en) | Method for manufacturing multilayer film, and multilayer film | |
EP3159949A4 (en) | Multilayer film and method for producing same |